Universe PharmaceuticalsUPC -2.81%58 Quick Ratio is 3.90 as of Sep. 2025, which is 52% above its 10-year median of 2.57. GuruFocus rates UPC with a GF Score™ of 58/100 and a GF Value™ of $5.22 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 997 Drug Manufacturers companies, Universe Pharmaceuticals ranks better than 83.85% on this metric.
Universe Pharmaceuticals has a quick ratio of 3.90. It generally indicates good short-term financial strength.
The historical rank and industry rank for Universe Pharmaceuticals's Quick Ratio or its related term are showing as below:
UPC'
s Quick Ratio Range Over the Past 10 Years
Min: 0.75 Med: 2.57 Max: 4.28
Current: 3.9
During the past 8 years, Universe Pharmaceuticals's highest Quick Ratio was 4.28. The lowest was 0.75. And the median was 2.57.
UPC's Quick Ratio is ranked better than 83.85% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs UPC: 3.90
Universe Pharmaceuticals (NAS:UPC) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Universe Pharmaceuticals Quick Ratio Related Terms
Universe Pharmaceuticals Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universe Pharmaceuticals Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Universe Pharmaceuticals's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Universe Pharmaceuticals's Quick Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universe Pharmaceuticals (UPC) has a Quick Ratio of 3.90 as of Sep. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Universe Pharmaceuticals and its competitors. This is 52% above median its historical median of 2.57. Over the past decade, Universe Pharmaceuticals' Quick Ratio has ranged from 0.75 to 4.28. According to the industry distribution chart, Universe Pharmaceuticals ranks #161 out of 997 companies in the Drug Manufacturers industry, placing it in the top 16.1%.
Is Universe Pharmaceuticals' Quick Ratio too high?
Universe Pharmaceuticals' current Quick Ratio of 3.90 is 52% above median its 10-year median of 2.57. Over the past 10 years, this metric has ranged from a low of 0.75 to a high of 4.28. The Drug Manufacturers industry median Quick Ratio is 1.45. Universe Pharmaceuticals' value of 3.90 is 169% above this industry median. Based on the distribution chart, Universe Pharmaceuticals ranks #161 out of 997 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Universe Pharmaceuticals has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Quick Ratio compare to CBIH and PRFX?
According to the Drug Manufacturers industry distribution chart, Universe Pharmaceuticals ranks #161 out of 997 companies for Quick Ratio. This places Universe Pharmaceuticals in the top 16% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Universe Pharmaceuticals' value of 3.90 is 169% above this benchmark. Historically, Universe Pharmaceuticals' own Quick Ratio has ranged from 0.75 to 4.28 over the past decade. While the company's 10-year median is 2.57 vs. the industry median of 1.45, Universe Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universe Pharmaceuticals's current Quick Ratio of 3.90 is 169% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Universe Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universe Pharmaceuticals's current Quick Ratio is 3.90, which is 52% above median its own 10-year median of 2.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Possible Value Trap. The stock's GF Value™ is $5.22, compared to a current price of $2.77 — trading 46.9% below its estimated fair value. The current Quick Ratio is 3.90, which is 52% above median its 10-year median of 2.57 and 169% above the Drug Manufacturers industry median of 1.45. Universe Pharmaceuticals' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Quick Ratio is 3.90 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universe Pharmaceuticals (UPC) Overvalued in 2026?
Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be undervalued.
The current stock price of $2.77 is trading 46.9% below its estimated GF Value™ of $5.22.
GuruFocus considers Universe Pharmaceuticals to be Possible Value Trap.
Key valuation signals for UPC:
Quick Ratio: 3.90 (52% above median its 10-year median of 2.57)
GF Value™: $5.22 vs. price of $2.77 (46.9% below fair value)
Industry Position: 169% above the Drug Manufacturers median (#161 of 997)
No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
58GF Score
Get the complete analysis for UPC
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UPC has been successfully added to your 
